Inside Innovation

After announcing it was raising a $6 million Series A last March, Curi Bio Inc., a Seattle life science startup has closed a $10 million

Since acquiring Celgene and its Seattle operations a couple years ago, Bristol Meyers Squibb (BMS) has been growing its presence in the Seattle area. Now,

Bristol Myers Squibb (BMS), which has several facilities in Washington state, is making significant advancements with Breyanzi, a CD19-directed CAR-T cell therapy as a second

A consortium to begin the development of the next COVID-19 vaccine is underway at The Infections Disease Research Institute (IDRI). The Washington-based non-profit is working

A new CBRE report reveals that as the life science industry continues to boom in the Seattle area, companies are buying out lab space and

Omeros, a Seattle-based biotech company, has announced it is selling its Omidria franchise to Rayner Surgical Group. Omidria helps to prevent excessive pupil constriction in

The Association of Washington Business has named David Hojah, Entrepreneur of the Year. Hojah is the CEO and Founder of Parrots Inc., a Spokane-based medical

Tune Therapeutics, a new biotech company with roots in Seattle, has developed TEMPO, a epigenomic therapy platform. TEMPO can find epigenomic elements contributing to genetic

Aptevo Therapeutics, a Seattle-based biotech company, has seen a 46% rise in stock price per share as a result of positive data from its ongoing

A new wearable device used to detect opioid overdoses is under development at the University of Washington. The device would be able to detect an

Anavasi Diagnostics, a Washington-based startup, has received a total of $20.9 million in funding from the U.S. National Institutes of Health and individual investors to

The Allen Institute has launched a new division focused on exploring how the brain learns, memorizes and executes other complex actions. Karel Svoboda will be